DEVELOPMENT AND ASSESSMENT OF A GUAVA-BASED TRANSDERMAL SYSTEM FOR ANTIDIABETIC THERAPY

Abstract

The study focuses on the development and evaluation of a transdermal drug delivery system (TDDS) incorporating guava (Psidium guajava) extract, targeting enhanced management of diabetes mellitus. Guava, known for its antidiabetic properties due to the presence of bioactive compounds such as flavonoids and polyphenols, offers a natural therapeutic alternative with minimal side effects.